Drug delivery, formulation

Biogen licenses subcutaneous drug delivery system for neurological drugs

12-Jan-2023 By Ben Hargreaves

Biogen partners with Alcyone to gain access to ThecaFlex, which is able to deliver therapies into the intrathecal space.

BioNTech links up with Ryvu on small molecule immunotherapy

06-Dec-2022 By Ben Hargreaves

BioNTech and Ryvu Therapeutics will collaborate to develop oncology programs, with the pair announcing that they will work together as part of a multi-target research collaboration.

CPI and 24 partners open £88m manufacturing innovation center

06-Dec-2022 By Ben Hargreaves

The collaborators unveil the facility after combing ideas from pharma and technology sectors to develop more sustainable manufacturing processes.

‘Innovators need to meet contract services partners sooner, plan much earlier and far further into development’

26-Oct-2022 By Rachel Arthur

A ‘significant shift’ is under way in global outsourcing strategies: with the sector moving away from phase-appropriate development in favor of a more forward-looking model – with experts advising starting the search for an outsourcing partner as early...

Heron scoops approval for IV postoperative nausea treatment

24-Oct-2022 By Ben Hargreaves

Heron Therapeutics receives approval for its intravenous (IV) injection version of aprepitant, which had previously only been delivered orally.

WuXi fills ‘capacity gap’ with HP facility in Wuxi city

04-Oct-2022 By Maggie Lynch

WuXi STA continues its growth and opens its first high potency oral drug product manufacturing facility at its Wuxi city campus.

TransCelerate CEO: Speeding drug development a ‘win-win’ for all concerned

28-Sep-2022

TransCelerate BioPharma continues to work towards “bringing new medicines to patients faster”. We caught up with the organization’s CEO to hear about its main achievements over the past decade and learn about what comes next.

Q&A: Precision for Medicine VP on the present & future of personalized medicine

27-Sep-2022

Outsourcing-Pharma caught up with Esther Mahillo, VP of Operational Strategy and Feasibility, Precision for Medicine to talk about advancements in patient enrollment in oncology and rare disease clinical trials.

Ensysce teams up with Quotient to develop opioid that prevents abuse, overdose

12-Sep-2022 By Nick Taylor

Ensysce Biosciences has partnered with Quotient Sciences to develop an opioid to prevent abuse and overdose, enabling it to make mid-study changes to the formulation based on emerging data.

Vaderis exits stealth as ex-Almac Discovery candidate enters clinical development

07-Sep-2022 By Nick Taylor

The clinical-stage biotechnology company is working on the advancement of a treatment for a blood vessel disorder that it licensed from the other company

Sanofi strikes $20m AI drug discovery deal with Atomwise

07-Sep-2022 By Nick Taylor

The pharma company’s collaboration with the drug discovery specialist involves using artificial intelligence to discover and develop up to five drug targets.

Lonza expanding dry powder inhalation capabilities at Florida site

01-Sep-2022 By Jenni Spinner

In response to rising demand for inhalable treatments geard toward respiratory conditions, the company is adding capabilities and capacity at its Tampa site.

Synthetic bio company Antheia raises $40m, announces new pilot plant

31-Aug-2022 By Jenni Spinner

The synthetic biology company which specializes in producing ingredients for plant-inspired medicines has a pilot-scale manufacturing facility in the works.

New WuXi STA plant to tackle growing HPAPI demand

31-Aug-2022 By Jenni Spinner

A company leader advises that the growing need for high-potency active pharmaceutical ingredients calls for CDMOs that consistently deliver quality at scale.

Cutting ‘pain points’ can streamline chemical reporting: ACD/Labs

30-Aug-2022 By Jenni Spinner

A representative from the R&D tech provider offers advice on how to wrangle with a stressful, complicated process for better results and fewer headaches.

Impel Pharmaceuticals reports progress with ASD-related drug trial

29-Aug-2022 By Jenni Spinner

The company reports dosing of the first subject in a Phase IIa proof-of-concept study investigating a drug for an autism spectrum disorder related condition.

Auransa, Polaris harness AI, quantum computing to discover cancer drugs

16-Aug-2022 By Jenni Spinner

The AI and QC specialists have joined to use AI and QC in order to discover biological pathways relevant to the treatment of triple-negative breast cancer.

Alzheimer’s research data questioned by Department of Justice

09-Aug-2022 By Jenni Spinner

After scientists and reporters raised red flags about a study, Cassava Sciences is being accused of falsifying data in pursuit of an Alzheimer’s treatment.

Pfizer to acquire sickle cell disease specialist for $5.4b USD

08-Aug-2022 By Jenni Spinner

Biopharmaceutical company Global Blood Therapeutics specializes in conditions that often disproportionately impact underrepresented communities, such as SCD.

Pharmanovia taps Nanoform to improve bioavailability of ‘iconic branded medicine’

08-Aug-2022 By Nick Taylor

The pharmaceutical company has forged a partnership with the nanotechnology specialist to use nanoparticle tech and formulation to advance its products.

People on the Move: July 2022

11-Jul-2022 By Jenni Spinner

This month’s announcements of launches, appointments, and partnerships includes Saama, COTA, Yourway, Eversana, Kindeva, and other notable industry companies.

Indiana University Health enlists LifeOmic platform for cancer research

06-Jul-2022 By Jenni Spinner

The academic research center has adopted the life science technology company’s cloud-based platform for cancer research, drug discovery, and clinical trials.

Eli Lilly gets speedy NICE recommendation for breast cancer treatment

06-Jul-2022 By Jenni Spinner

England's cost-effectiveness watchdog has recommended Eli Lilly’s Verzenios treatment as an option for adjuvant treatment of certain forms of breast cancer.

bio 2022

BIO unveils its executive committee directors for 2022-2023 term

16-Jun-2022 By Jenni Spinner

The Biotechnology Innovation Organization elected the fresh slate of leaders during the BIO International Convention, taking place in San Diego this week.

Lilly invests $2.1bn in new Indiana manufacturing sites

31-May-2022 By Rachel Arthur

Eli Lilly and Company plans to expand its manufacturing footprint in Indiana by investing $2.1bn in two new manufacturing sites at Indiana's LEAP Lebanon Innovation and Research District in Boone County.

Standigm uses AI to discover potential Crohn’s disease treatment

24-May-2022 By Jenni Spinner

The drug company, which uses artificial intelligence to discover and advance repurposed drugs, is harnessing the technology to find a treatment for Crohn’s.

NIH awards $577m to antiviral drug developers

20-May-2022 By Rachel Arthur

The National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health, has awarded a total of $577m to establish nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.

FDA lifts clinical hold on Gilead’s investigational HIV treatment

17-May-2022 By Jenni Spinner

The agency has removed the hold placed on the pharmaceutical company’s IND for injectable lenacapavir, which is intended for HIV treatment and prevention.

Novartis looks to work more strategically as CDMO

16-May-2022 By Jane Byrne

Novartis has recently set up a new contract development and manufacturing unit called Global Biotech Co-operations (GBTC).

AstraZeneca metastatic breast cancer treatment secures FDA approval

10-May-2022 By Jenni Spinner

The US agency has approved Enhertu for patients diagnosed with HER2-positive metastatic breast cancer previously treated with an anti-HER2-based regimen.

FDA outlines benefit-risk approach to drug or biologic product quality assessment

10-May-2022 By Jane Byrne

The US FDA released new draft guidance yesterday discussing, among other challenges, how unresolved product quality issues might be addressed in the context of regulatory decision-making.

TFF: Phase I study of inhalable COVID-19 drug shows promise

09-May-2022 By Jenni Spinner

The thin-film freezing specialist reports positive safety and pharmacokinetic data coming out of the Phase I trial of its niclosamide inhalation powder.

Illumina secures drug discovery tie-ups with Janssen, Deerfield

09-May-2022 By Jane Byrne

Illumina has recently announced a 10-year-long strategic collaboration with Janssen Biotech, and a five-year partnership with Deerfield Management.

FDA approves expanded indication for ADHD treatment from Supernus

02-May-2022 By Jenni Spinner

The agency has approved an expanded indication for Qelbree extended-release capsules to treat attention deficit hyperactivity disorder in younger patients.

Sionna raises $111m to take molecules against CF target into the clinic

28-Apr-2022 By Nick Taylor

Newly launched life sciences company Sionna Therapeutics has secured funding to fuel discovery and development of drug candidates to treat cystic fibrosis.

Impel Pharmaceuticals upper-nasal delivery offers hope for migraine patients

26-Apr-2022 By Jenni Spinner

The company’s Precision Olfactory Delivery technology, currently combined with its Trudhesa migraine treatment, reportedly facilitates high absorption rates.

FDA approves label update to ViiV’s long-acting HIV treatment

25-Apr-2022 By Jenni Spinner

The US Food and Drug Administration has approved a move to make the oral lead-in period for ViiV Healthcare’s once-every-other-month drug Cabenuva optional.

Catalent to invest $350m to expand US drug substance and product manufacturing site

22-Apr-2022 By Jane Byrne

Catalent has announced a multi-year $350m investment at its facility in Bloomington, Indiana, to expand biologics drug substance and drug product manufacturing capabilities.

Inke to triple capacity for inhalation API manufacturing

20-Apr-2022 By Jenni Spinner

The maker of active pharmaceutical ingredients for inhaled treatments is investing €9m ($9.8m USD) to expand its manufacturing plant in Barcelona, Spain.

CMC lands funding to develop treatment for nerve agent poisoning

19-Apr-2022 By Jenni Spinner

The CDMO has been awarded funding from the US government to work on treatments for sarin and other substances used frequently employed in chemical attacks.

Women hold power in clinical research arena: Greenphire

12-Apr-2022 By Jenni Spinner

A recent online event hosted by the patient services company invited a number of women to share their experience and insights working in the research field.

DFE Pharma, Harro Höfliger, and Sterling forge respiratory partnership

06-Apr-2022 By Jenni Spinner

The excipients, equipment, and API companies have joined forces on Inhalation Together, an initiative aimed at advancing dry-powder inhalation solutions.

Novartis announces new organizational structure

05-Apr-2022 By Rachel Arthur

Novartis has created a new organizational structure and operating model: which it says will make the company more agile and competitive.

AbbVie, Gedeon Richter to partner on developing neuropsychiatric drugs

15-Mar-2022 By Jenni Spinner

The US- and Hungary-based pharma firms will work on research, development, and commercialization of dopamine receptor modulators for potential treatments.

Enveric taps University of Calgary to study psychedelic therapy in cancer-related distress

14-Mar-2022 By Nick Taylor

The pharma company and academic institution will explore the viability of a psychedelic treatment to help patients suffering from cancer-related distress.

Pfizer, CytoReason extend AI pact after immune system success

08-Mar-2022 By Nick Taylor

The drug company has renewed its arrangement with the artificial intelligence specialist, centered on using AI to improve understanding of the immune system.

Stanford laboratory aligns with Pepper Bio to target tough cancers

03-Mar-2022 By Jenni Spinner

The drug discovery firm will work with the Dean Felsher Laboratory, using the company’s transomics platform to discover therapies for untreatable cancers.

People on the Move: March 2022

03-Mar-2022 By Jenni Spinner

This month’s announcements include hiring, expansion, and acquisition news from companies like DFE Pharma, ClinOne, Novartis, LEGO, Benchling, and more.

DCAT week 2022

DCAT Week 2022 to explore ‘what’s next for the industry’

03-Mar-2022 By Jenni Spinner

Returning to an in-person format March 21-24, the industry event is bringing a range of networking, educational, and social programming to New York City.

Collaboration to advance development of cancer therapies

14-Feb-2022 By Jenni Spinner

Cullinan Oncology has formed a strategic partnership with the Icahn School of Medicine at Mount Sinai to research and develop targeted therapies for cancer.